These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28125889)

  • 1. Micro RNA-126 coordinates cell behavior and signaling cascades according to characteristics of breast cancer cells.
    Turgut Cosan D; Oner C; Mutlu Sahin F
    Bratisl Lek Listy; 2016; 117(11):639-647. PubMed ID: 28125889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressing the molecular signaling pathways involved in inflammation and cancer in breast cancer cell lines MDA-MB-231 and MCF-7 by miR-590.
    Sheikholeslami A; Nabiuni M; Arefian E
    Tumour Biol; 2017 Apr; 39(4):1010428317697570. PubMed ID: 28443471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-200b Impacts Breast Cancer Cell Migration and Invasion by Regulating Ezrin-Radixin-Moesin.
    Hong H; Yu H; Yuan J; Guo C; Cao H; Li W; Xiao C
    Med Sci Monit; 2016 Jun; 22():1946-52. PubMed ID: 27276064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
    Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [miR-101 inhibits the proliferation and migration of breast cancer cells via downregulating the expression of DNA methyltransferase 3a].
    Liu J; Pang Y; Wang H; Li Y; Sun X; Xu F; Ren H; Liu D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):299-303. PubMed ID: 26927545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
    Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
    Piperigkou Z; Franchi M; Götte M; Karamanos NK
    Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-155 promotes the proliferation and migration of breast cancer cells via targeting SOCS1 and MMP16.
    Zhang W; Chen CJ; Guo GL
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7323-7332. PubMed ID: 30468477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer.
    Mutlu M; Saatci Ö; Ansari SA; Yurdusev E; Shehwana H; Konu Ö; Raza U; Şahin Ö
    Sci Rep; 2016 Sep; 6():32541. PubMed ID: 27600857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the dual-faced effects of miR-141 with chitosan/miR-141 nanoplexes in breast cancer cells.
    Kaban K; Salva E; Akbuga J
    J Gene Med; 2019 Sep; 21(9):e3116. PubMed ID: 31389101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
    Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
    Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-7 suppresses the homing and migration potential of human endothelial cells to highly metastatic human breast cancer cells.
    Cui YX; Bradbury R; Flamini V; Wu B; Jordan N; Jiang WG
    Br J Cancer; 2017 Jun; 117(1):89-101. PubMed ID: 28571043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
    Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
    Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer.
    Luo LJ; Yang F; Ding JJ; Yan DL; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH
    Gene; 2016 Dec; 594(1):47-58. PubMed ID: 27593563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
    Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
    Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
    Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
    Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.